Our Team

Leadership Team

Dan Marquess
Dan Marquess
CSO
Read More
Joe Budman
Joe Budman
VP of Biology
Read More

Board of Directors

Dan Nomura
Dan Nomura
Founder
Cam Wheeler
Cam Wheeler
Partner, Deerfield Management
Jorge Conde
Jorge Conde
Partner, a16z Bio
George Golumbeski
George Golumbeski
Partner, Droia Ventures

Scientifc Advisory Board

Angela Koehler
Angela Koehler
Professor, MIT
Dan Nomura
Dan Nomura
Founder
F. Dean Toste
F. Dean Toste
Professor, UC Berkeley
James Olzmann
James Olzmann
Professor, UC Berkeley
Kevan Shokat
Kevan Shokat
Professor, HHMI/UCSF
Michael Rape
Michael Rape
Professor, HHMI/UC Berkeley
Thomas Maimone
Thomas Maimone
Professor, UC Berkeley

Investors

Joe Budman
VP of Biology
Joe is an experienced drug hunter with a technical background in biochemistry, molecular pharmacology, and cell/molecular biology. He is a biology and project team leader with over 20 years of diverse experiences from small molecule drug discovery to early clinical development. Joe was previously Senior Director, Biology and Pharmacology at Theravance Biopharma, where he led the in vitro pharmacology group as well as the company’s Ophthalmology research program. His team defined, developed, executed, and optimized key experiments in the research critical path and performed detailed pharmacologic characterization of molecules for IND submission. These efforts led to the discovery of numerous development candidates and clinical compounds across various therapeutic areas and target classes. Joe received his PhD from Stanford, where he investigated DNA repair by non-homologous end-joining with Professor Gilbert Chu in the departments of Biochemistry and Oncology. Prior to his graduate studies, he worked on understanding the substrate specificity of signaling molecules in Lewis Cantley’s lab at Harvard. Joe received his BS degree from MIT and he strives to develop a strong quantitative understanding of drug and pathway pharmacology for all of his projects.
Dan Marquess
CSO
Dan Marquess is the Chief Scientific Officer at Vicinitas Therapeutics. Prior to Vicinitas, he was the Chief Scientific Officer at an emerging oncology company funded by Versant Ventures focused on a novel chemoproteomics-mass spec platform to study native protein complexes. He also served as the Chief Scientific Officer at UNITY Biotechnology, an ARCH-funded company, leading the company's Discovery and Early Development efforts to eliminate senescent cells to slow, halt and reverse diseases of ageing. UNITY’s most advanced clinical candidate, UBX1325-a Bcl-XL inhibitor, is now in Phase 2 clinical studies for treatment of age-related diseases of the retina, such as age-related degeneration and diabetic retinopathies. Prior to UNITY, Dan was Vice President and Head of Medicinal Chemistry at Theravance Biopharma, where he led the chemistry department to leverage Theravance's multivalent approach to drug discovery in anti-infective, respiratory, gastrointestinal and immunology therapeutic areas-these efforts contributed the approval of five medicines. Dan started his career at GSK, Stevenage, UK as a medicinal chemist in neuroscience discovery. Dan holds a DPhil in Organic Chemistry from the University of Oxford and a BSc in Chemistry from the Queen's University, Belfast, N. Ireland. He was awarded a NATO postdoctoral fellowship to conduct chemistry research with Professor Paul Wender at Stanford University to complete the total synthesis of the anticancer agent, Taxol. He has authored ~44 papers published in peer-reviewed journals and is an inventor on ~21 patents.
Dan Nomura
Founder, Professor of Chemistry at UC Berkeley, Scientific Advisor
Coming Soon!
Cam Wheeler
Partner, Deerfield Management
Coming Soon!
Jorge Conde
Partner, a 16z Bio
Coming Soon!
George Golumbeski
Partner, a 16z Bio
Coming Soon!
F. Dean Toste
Professor, UC Berkeley
Coming Soon!
Michael Rape
Professor, HHMI/UC Berkeley
Coming Soon!
Kevan Shokat
Professor, HHMI/UCSF
Coming Soon!
James Olzmann
Professor, UC Berkeley
Coming Soon!
Thomas Maimone
Professor, UC Berkeley
Coming Soon!
Angela Koehler
Professor, MIT
Coming Soon!